pubmed-article:15846270 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:15846270 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:15846270 | lifeskim:mentions | umls-concept:C0031809 | lld:lifeskim |
pubmed-article:15846270 | lifeskim:mentions | umls-concept:C0004238 | lld:lifeskim |
pubmed-article:15846270 | lifeskim:mentions | umls-concept:C0205245 | lld:lifeskim |
pubmed-article:15846270 | lifeskim:mentions | umls-concept:C0205178 | lld:lifeskim |
pubmed-article:15846270 | lifeskim:mentions | umls-concept:C0013778 | lld:lifeskim |
pubmed-article:15846270 | lifeskim:mentions | umls-concept:C0679199 | lld:lifeskim |
pubmed-article:15846270 | lifeskim:mentions | umls-concept:C0206054 | lld:lifeskim |
pubmed-article:15846270 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
pubmed-article:15846270 | lifeskim:mentions | umls-concept:C1516240 | lld:lifeskim |
pubmed-article:15846270 | pubmed:issue | 2 | lld:pubmed |
pubmed-article:15846270 | pubmed:dateCreated | 2005-4-22 | lld:pubmed |
pubmed-article:15846270 | pubmed:abstractText | The ACUTE Trial studied a transesophageal echocardiography (TEE)-guided strategy compared with a conventional strategy for management of patients with atrial fibrillation undergoing direct current cardioversion. The primary aim was to determine if patient functional capacity, measured by the Duke Activity Status Index (DASI), would differ between treatment strategies. | lld:pubmed |
pubmed-article:15846270 | pubmed:language | eng | lld:pubmed |
pubmed-article:15846270 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15846270 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:15846270 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15846270 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:15846270 | pubmed:month | Feb | lld:pubmed |
pubmed-article:15846270 | pubmed:issn | 1097-6744 | lld:pubmed |
pubmed-article:15846270 | pubmed:author | pubmed-author:KleinAllan... | lld:pubmed |
pubmed-article:15846270 | pubmed:author | pubmed-author:GrimmRichard... | lld:pubmed |
pubmed-article:15846270 | pubmed:author | pubmed-author:Apperson-Hans... | lld:pubmed |
pubmed-article:15846270 | pubmed:author | pubmed-author:MurrayR... | lld:pubmed |
pubmed-article:15846270 | pubmed:author | pubmed-author:PapeLinda ALA | lld:pubmed |
pubmed-article:15846270 | pubmed:author | pubmed-author:JasperSusan... | lld:pubmed |
pubmed-article:15846270 | pubmed:author | pubmed-author:LieberElizabe... | lld:pubmed |
pubmed-article:15846270 | pubmed:author | pubmed-author:BlackIan WIW | lld:pubmed |
pubmed-article:15846270 | pubmed:author | pubmed-author:ACUTE... | lld:pubmed |
pubmed-article:15846270 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:15846270 | pubmed:volume | 149 | lld:pubmed |
pubmed-article:15846270 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:15846270 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:15846270 | pubmed:pagination | 309-15 | lld:pubmed |
pubmed-article:15846270 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:15846270 | pubmed:meshHeading | pubmed-meshheading:15846270... | lld:pubmed |
pubmed-article:15846270 | pubmed:meshHeading | pubmed-meshheading:15846270... | lld:pubmed |
pubmed-article:15846270 | pubmed:meshHeading | pubmed-meshheading:15846270... | lld:pubmed |
pubmed-article:15846270 | pubmed:meshHeading | pubmed-meshheading:15846270... | lld:pubmed |
pubmed-article:15846270 | pubmed:meshHeading | pubmed-meshheading:15846270... | lld:pubmed |
pubmed-article:15846270 | pubmed:meshHeading | pubmed-meshheading:15846270... | lld:pubmed |
pubmed-article:15846270 | pubmed:meshHeading | pubmed-meshheading:15846270... | lld:pubmed |
pubmed-article:15846270 | pubmed:meshHeading | pubmed-meshheading:15846270... | lld:pubmed |
pubmed-article:15846270 | pubmed:meshHeading | pubmed-meshheading:15846270... | lld:pubmed |
pubmed-article:15846270 | pubmed:meshHeading | pubmed-meshheading:15846270... | lld:pubmed |
pubmed-article:15846270 | pubmed:meshHeading | pubmed-meshheading:15846270... | lld:pubmed |
pubmed-article:15846270 | pubmed:meshHeading | pubmed-meshheading:15846270... | lld:pubmed |
pubmed-article:15846270 | pubmed:meshHeading | pubmed-meshheading:15846270... | lld:pubmed |
pubmed-article:15846270 | pubmed:meshHeading | pubmed-meshheading:15846270... | lld:pubmed |
pubmed-article:15846270 | pubmed:year | 2005 | lld:pubmed |
pubmed-article:15846270 | pubmed:articleTitle | Impact of cardioversion strategy on functional capacity in patients with atrial fibrillation: the Assessment of Cardioversion Using Transesophageal Echocardiography (ACUTE) study. | lld:pubmed |
pubmed-article:15846270 | pubmed:affiliation | Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA. | lld:pubmed |
pubmed-article:15846270 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:15846270 | pubmed:publicationType | Comparative Study | lld:pubmed |
pubmed-article:15846270 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |